LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Does Extended Oral Antibiotic Prophylaxis Work?
Large Joints and Extremities

Does Extended Oral Antibiotic Prophylaxis Work?

August 10, 2022 2 min read Premium comments

Advertisement

#totalhiparthroplastySecondary#asepticrevision#extendedoralantiobioticprophylaxis

How well (or not) does extended oral antibiotic prophylaxis work after aseptic revision total hip arthroplasty (THA)? A team of researchers from Mayo Clinic in Minnesota designed a retrospective study and collected data from 1,107 aseptic revision THAs to see if an answer to that question emerged.

The research, “Extended Oral Antibiotic Prophylaxis After Aseptic Revision Total Hip Arthroplasty: Does It Decrease Infection Risk?” was published in the July 4, 2022, edition of The Journal of Arthroplasty.

Matthew Abdel, M.D., Andrew A. and Mary S. Sugg Professor of Orthopedic Surgery and chair of the Division of Orthopedic Surgery Research at Mayo Clinic and co-author described the genesis of this study to OTW, “Extended oral antibiotic prophylaxis is becoming more common after a landmark study by Dr. Michael Meneghini showing decreased risk of infection in high-risk patients undergoing primary arthroplasties.”

“In revision procedures, those are some of the highest risk patients, and at Mayo Clinic, a subset of us have been providing extended oral antibiotic prophylaxis for 7-, 10-, or 14-days while awaiting intraoperative cultures for the past 10 years.”

For this study, the researchers looked at a subset of 370 patients who received extended oral antibiotic prophylaxis >24 hours perioperatively, comparing them to 737 who did not. Their outcomes of interest included cumulative probabilities of any infection, periprosthetic joint infection (PJI), and re-revision or reoperation for infection.

Using the 2011 Musculoskeletal Infection Society criteria, the researchers defined aseptic revision THA as “a surgical intervention involving arthroplasty of at least one component, including isolated head-liner exchanges, and no evidence of infection.” All procedures were done at the same institution and every patient received the same standardized perioperative care according to the Mayo Clinic total joint pathway.

The researchers found that the cumulative probability of any infection after aseptic revision THA was 2.3% at 90 days, 2.7% at 1 year, and 3.5% at 5 years. The cumulative probability of PJI was 1.7% at 90 days, 2.1% at 1 year, and 2.8% at 5 years.

“In this study,” explained Dr. Abdel to OTW, “we found a trend towards increased risk of any infection (Hazard Ratio=2.6), PJI (Hazard Ratio=2.6), and re-revision (Hazard Ratio=6.5), and or reoperation (Hazard Ratio=2.3) for infection in patients who did not have extended oral antibiotic prophylaxis at final clinical follow-up.”

“This is important as revision procedures often include extensive tibial and femoral fixation that is more difficult to remove when infection occurs, and things we can do to prevent such infections is paramount.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy